Clinical Trial Update: The Effect of Pentoxifylline on Liver Function Tests in Fatty Liver Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating pentoxifylline for improving liver function in non-alcoholic fatty liver disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Drugs mentioned

• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Fatty Liver | Phase 2 | Status: COMPLETED